Two cannabis stocks have high potential to double (or perhaps triple) in value.

The cannabis business in the United States has exploded in recent years, with 36 states legalizing the drug for medical or recreational use, or both, and many more decriminalizing it. Cannabis remains an illegal drug at the federal level, although federal law also prevents prosecution of users who follow local state laws.

However, the sector is confronting a variety of challenges, the most significant of which is political. This, like so many other headwinds these days, stems from Washington’s party gridlock. Because Congress and the Biden Administration are having difficulty passing significant legislation, second-tier goals, such as cannabis legalization, are taking a back seat.

This hasn’t prevented the business from making money. Revenues are increasing as firms expand their sales operations into as many states as possible, both in the medicinal and recreational sectors, as well as any other miscellaneous and incidentals that cannabis manufacturers may think of. Long-term investors are still hopeful that cannabis will be legalized in the United States over the next several years.

As a result, Pablo Zuanic, a Cantor analyst, is optimistic about the cannabis industry’s long-term prospects. He believes that most of the current grow businesses have lots of…